Lack of restriction of T cell receptor β variable gene usage in cerebrospinal fluid lymphocytes in acute optic neuritis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 67, Issue 5, 1999, Pages 585-590

  Heard, R N S ^a,b   Teutsch, S M ^a,b   Bennetts, B H ^c   Lee, S D ^a,b   Deane, E M ^d   Stewart, G J ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Cerebrospinal fluid; Optic neuritis; T cell receptor usage

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN G; RNA; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DENSITOMETRY; FEMALE; GENE EXPRESSION; HUMAN; HYPOTHESIS; MALE; MULTIGENE FAMILY; MULTIPLE SCLEROSIS; OLIGONUCLEOTIDE PROBE; OPTIC NERVE DISEASE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE;

EID: 0032860866     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.67.5.585     Document Type: Article

References (39)

1. Hafler DA, Duby AD, Lee SJ, et al. Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1988;167:1313-22.
2. Zamvil SS, Mitchell DJ, Moore AC, et al. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 1986;324:258-60.
3. Acha-Orbea H, Mitchell DJ, Timmermann L, et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 1988;54:263-73.
4. Burns FR, Li X, Shen N, et al. Both rat and mouse T-cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα- and Vβ-chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J Exp Med 1989;169:27-39.
5. Offner H, Hashim GA, Vandenbark AA. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 1991;251:430-2.
6. Kotzin BL, Karutri S, Chou YK, et al. Preferential T-cell receptor β-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 1991;88:9161-5.
7. Oksenberg JR, Panzara MA, Begovich AB, et al. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993;362:68-70.
8. Bourdette DN, Whitham RH, Chou YK, et al. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic Vβ5.2 and Vβ6.1 CDR2 peptides. J Immunol 1994;152:2510-9.
9. Chou YK, Morrison WJ, Weinberg AD, et al. Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of Vβ5.2 and Vβ6.1 CDR2 peptides. J Immunol 1994;152: 2520-9.
10. Vandenbark AA, Chou YK, Whitham R, et al. Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat Med 1996;2:1109-15.
11. Bourdette DN, Chou YK, Whitham RH, et al. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. J Immunol 1998;161:1034-44.
12. Wilson DB, Golding AB, Smith RA, et al. Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. I. analysis of T-cell receptor utililization in CSF cell populations. J Neuroimmunol 1997;76:15-28.
13. Gold DP, Smith RA, Golding AB, et al. Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utililization in CSF T-cell populations before and after vaccination with a TCRVβ6 CDR2 peptide. J Neuroimmunol 1997;76:29-38.
14. Wucherpfennig KW, Ota K, Endo N, et al. Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 1990;248:1016-9.
15. Ben-Nun A, Liblau RS, Cohen L, et al. Restricted T-cell receptor Vβ gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc Natl Acad Sci USA 1991;88:2466-70.
16. Muraro PA, Vergelli M, Kalbus M, et al. Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. J Clin Invest 1997;100:339-49.
17. Wucherpfennig KW, Newcombe J, Li H, et al. T cell receptor Vα-Vβ repertoire and cytokine gene expression in active multiple sclerosis lesions. J Exp Med 1992;175:993-1002.
18. Correale J, McMillan M, McCarthy K, et al. Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurology 1995;45:1370-8.
19. Richert JR, Robinson ED, Camphausen K, et al. Diversity of the T-cell receptor Vα, Vβ, and CDR3 expression by myelin basic protein-specific human T-cell clones. Neurology 1995; 45:1919-22.
20. Lehmann PV, Forsthuber T, Miller A, et al. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-7.
21. Navarrete C, Bottazzo GF. In search of TCR restriction in autoreactive T cell in human autoimmunity: why is it so elusive? Clin Exp Immunol 1993;91:189-92.
22. Poser CM, Sheinberg L, McDonald WI, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
23. Miller DH, Ormerod IEC, McDonald WI, et al. The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry 1988;51:1569-71.
24. Sandberg-Wollheim M, Bynke H, Cronqvist S, et al. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 1990;27:386-93.
25. Sambrook J, Fitsch EF, Maniatis T. Molecular cloning. A laboratory manual. 2nd ed. New York: Cold Spring Harbour Laboratory Press, 1989;8:11-13.
26. Choi Y, Kotzin B, Herren L, et al. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 1989;86:8941-5.
27. Genevée C, Diu A, Nierat J, et al. An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 1992;22:1261-9.
28. Chou YK, Buenafe A, Dedrick R, et al. T cell receptor Vβ gene usage in the recognition of myelin basic protein by from cerebrospinal fluid- and blood-derived T cells from patients with multiple sclerosis. J Neurosci Res 1994;37: 169-81.
29. Usuku K, Joshi N, Hatem CJ Jr, et al. Biased expression of T cell receptor genes characterizes activated T cells in multiple sclerosis cerebrospinal fluid. J Neurosci Res 1996;45: 829-37.
30. Birebent B, Semana G, Commeurec A, et al. TCR repertoire and cytokine profiles of cerebrospinal fluid- and peripheral blood-derived T lymphocytes from patients with multiple sclerosis. J Neurosci Res 1998;51:759-70.
31. Jason J, Inge KL. The effects of mitogens, IL-2 and anti-CD3 antibody on the T-cell receptor Vβ repertoire. Scand J Immunol 1996;43:652-61.
32. Satyanarayana K, Chou YK, Bourdette DN, et al. Epitope specificity and V gene expression of cerebrospinal fluid T cells specific for intact versus cryptic epitopes of myelin basic protein. J Neuroimmunol 1993;44:57-68.
33. Lee SJ, Wucherpfennig KW, Brod SA, et al. Common T-cell receptor Vβ usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Ann Neurol 1991;29:33-40.
34. Birnbaum G, Van Ness B. Quantitation of T-cell receptor Vβ chain expression on lymphocytes from blood, brain, and spinal fluid in patients with multiple sclerosis and other neurological diseases. Ann Neurol 1992;32:24-30.
35. Miller SD, Vanderlugt CL, Smith Begolka W, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997;3:1133-6.
36. Lee KH, Hashimoto SA, Hooge JP, et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2 year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1991;41:657-60.
37. Morrissey SP, Miller DH, Kendall BE, et al. The significance of brain magnetic resonance abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 1993;116:135-46.
38. O'Riordan JI, Losseff NA, Phatouros C, et al. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J Neurol Neurosurg Psychiatry 1998;64:353-7.
39. Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 1993;329:1764-9.